Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy
Antigoni Manousopoulou, Maureen Gatherer, Colin Smith, et al.
Neuropathology and Applied Neurobiology (2016) Vol. 43, Iss. 6, pp. 492-504
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Steven M. Greenberg, Brian J. Bacskai, Mar Hernández‐Guillamón, et al.
Nature Reviews Neurology (2019) Vol. 16, Iss. 1, pp. 30-42
Open Access | Times Cited: 634
Emerging concepts in sporadic cerebral amyloid angiopathy
Andreas Charidimou, Grégoire Boulouis, M. Edip Gurol, et al.
Brain (2017) Vol. 140, Iss. 7, pp. 1829-1850
Open Access | Times Cited: 439
Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways
Aleksandra Wojtas, Silvia S. Kang, Benjamin M. Olley, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 33
Open Access | Times Cited: 115
HDL from an Alzheimer's disease perspective
Emily B. Button, Jérôme Robert, Tara M. Caffrey, et al.
Current Opinion in Lipidology (2019) Vol. 30, Iss. 3, pp. 224-234
Open Access | Times Cited: 93
Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer’s disease
David Hondius, Kristel N. Eigenhuis, Tjado H. J. Morrema, et al.
Acta Neuropathologica Communications (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 81
CADASIL brain vessels show a HTRA1 loss-of-function profile
Andreas Zellner, Eva Scharrer, Thomas Arzberger, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 1, pp. 111-125
Closed Access | Times Cited: 67
Transendothelial transport of lipoproteins
Erika Jang, Jérôme Robert, Lucia Rohrer, et al.
Atherosclerosis (2020) Vol. 315, pp. 111-125
Closed Access | Times Cited: 67
Proteomics of neurodegenerative diseases: analysis of human post‐mortem brain
Ka Wan Li, Andrea B. Ganz, August B. Smit
Journal of Neurochemistry (2018) Vol. 151, Iss. 4, pp. 435-445
Open Access | Times Cited: 62
Differences in the cerebral amyloid angiopathy proteome in Alzheimer’s disease and mild cognitive impairment
Dominique Leitner, Tomas Kavanagh, Evgeny Kanshin, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 7
Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates
Andreas Zellner, Stephan A. Müller, Barbara Lindner, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 28
Longitudinal markers of cerebral amyloid angiopathy and related inflammation in rTg-DI rats
Joseph M. Schrader, Feng Xu, Kevin Agostinucci, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta
Emma M. Lofthouse, Christopher Torrens, Antigoni Manousopoulou, et al.
The FASEB Journal (2019) Vol. 33, Iss. 7, pp. 8211-8220
Open Access | Times Cited: 39
The Diverse Roles of TIMP-3: Insights into Degenerative Diseases of the Senescent Retina and Brain
Jennifer M. Dewing, Roxana O. Carare, Andrew Lotery, et al.
Cells (2019) Vol. 9, Iss. 1, pp. 39-39
Open Access | Times Cited: 38
The pleiotropic vasoprotective functions of high density lipoproteins (HDL)
Boyce Guilaine, Button Emily, S.V. Sonja, et al.
Journal of Biomedical Research (2017) Vol. 32, Iss. 3, pp. 164-164
Open Access | Times Cited: 39
Quantitative proteomic profiling of primary cancer-associated fibroblasts in oesophageal adenocarcinoma
Antigoni Manousopoulou, Annette Hayden, Massimiliano Mellone, et al.
British Journal of Cancer (2018) Vol. 118, Iss. 9, pp. 1200-1207
Open Access | Times Cited: 34
Systems spatiotemporal dynamics of traumatic brain injury at single-cell resolution reveals humanin as a therapeutic target
Douglas Arneson, Guanglin Zhang, In Sook Ahn, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 9
Open Access | Times Cited: 18
Brevican and Neurocan Cleavage Products in the Cerebrospinal Fluid - Differential Occurrence in ALS, Epilepsy and Small Vessel Disease
Wilhelm Hußler, Lukas Höhn, Christopher Stolz, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 17
Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
Jessica Camacho, Teresa Moliné, Anna Bonaterra‐Pastra, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 28
APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brains
Joseph Ojo, Jon M. Reed, Gogce Crynen, et al.
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Experimental approaches for altering the expression of Abeta‐degrading enzymes
David A. Loeffler
Journal of Neurochemistry (2023) Vol. 164, Iss. 6, pp. 725-763
Open Access | Times Cited: 9
Proportions of Basement Membrane Proteins in Cerebrovascular Smooth Muscle Cells After Exposure to Hypercapnia and Amyloid Beta
Jennifer M. Dewing, Abby Keable, Alexandru Laslo, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 614-614
Open Access
Quantitative Proteomic Analysis To Identify Differentially Expressed Proteins in Myocardium of Epilepsy Using iTRAQ Coupled with Nano-LC–MS/MS
Peng Zhang, Li Zhang, Yongguo Li, et al.
Journal of Proteome Research (2017) Vol. 17, Iss. 1, pp. 305-314
Closed Access | Times Cited: 27
Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease
Eleanor Drummond, Fernando Goñi, Shan Liu, et al.
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. s1, pp. S299-S312
Closed Access | Times Cited: 24
Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy
Yoshinori Endo, Kazuhiro Hasegawa, Ryo Nomura, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top